Insiders · ABEO

ABEO insider transactions

Abeona Therapeutics Inc. (ABEO) Form 4 insider transactions - real-time wire coverage of every officer, director, and 10% owner trade.

Recent Form 3, 4, and 5 filings for ABEO

• 13d
  Director Alvino Mark gifted 500 shares, decreasing direct ownership by 0.64% to 77,065 units (SEC Form 4)

  4 - ABEONA THERAPEUTICS INC. (0000318306) (Issuer)
• 17d
  Director Alvino Mark sold $35,463 worth of shares (6,500 units at $5.46), decreasing direct ownership by 8% to 77,565 units (SEC Form 4)

  4 - ABEONA THERAPEUTICS INC. (0000318306) (Issuer)
• 24d
  Director Crombez Eric sold $144,636 worth of shares (26,143 units at $5.53) as part of a pre-agreed trading plan, decreasing direct ownership by 41% to 37,313 units (SEC Form 4)

  4 - ABEONA THERAPEUTICS INC. (0000318306) (Issuer)
• 27d
  Chief Commercial Officer Vasanthavada Madhav sold $33,073 worth of shares (5,548 units at $5.96), decreasing direct ownership by 2% to 313,071 units (SEC Form 4) to satisfy withholding obligation

  4 - ABEONA THERAPEUTICS INC. (0000318306) (Issuer)
• 62d
  SEC Form 4 filed by Goldan Keith A.

  4 - ABEONA THERAPEUTICS INC. (0000318306) (Issuer)
• 62d
  SEC Form 3 filed by new insider Goldan Keith A.

  3 - ABEONA THERAPEUTICS INC. (0000318306) (Issuer)
• 68d
  SEC Form 4 filed by Seshadri Vishwas

  4 - ABEONA THERAPEUTICS INC. (0000318306) (Issuer)
• 84d
  Chief Financial Officer Vazzano Joseph Walter sold $3,737 worth of shares (785 units at $4.76), decreasing direct ownership by 0.14% to 567,775 units (SEC Form 4)

  4 - ABEONA THERAPEUTICS INC. (0000318306) (Issuer)
• 124d
  Director Silverstein Christine Berni sold $102,168 worth of shares (20,070 units at $5.09), decreasing direct ownership by 13% to 137,722 units (SEC Form 4)

  4 - ABEONA THERAPEUTICS INC. (0000318306) (Issuer)
• 125d
  Director Wuchterl Donald A. sold $75,412 worth of shares (14,814 units at $5.09), decreasing direct ownership by 8% to 167,935 units (SEC Form 4)

  4 - ABEONA THERAPEUTICS INC. (0000318306) (Issuer)
• 125d
  Director Crombez Eric sold $82,895 worth of shares (16,284 units at $5.09), decreasing direct ownership by 20% to 63,456 units (SEC Form 4)

  4 - ABEONA THERAPEUTICS INC. (0000318306) (Issuer)
• 126d
  Director Alland Leila sold $91,962 worth of shares (18,065 units at $5.09), decreasing direct ownership by 9% to 173,614 units (SEC Form 4)

  4 - ABEONA THERAPEUTICS INC. (0000318306) (Issuer)
• 126d
  Director Alvino Mark sold $10,181 worth of shares (2,000 units at $5.09), decreasing direct ownership by 2% to 84,065 units (SEC Form 4)

  4 - ABEONA THERAPEUTICS INC. (0000318306) (Issuer)
• 132d
  Director Crombez Eric was granted 37,313 shares, increasing direct ownership by 88% to 79,740 units (SEC Form 4)

  4 - ABEONA THERAPEUTICS INC. (0000318306) (Issuer)
• 132d
  Director Wuchterl Donald A. was granted 37,313 shares, increasing direct ownership by 26% to 182,749 units (SEC Form 4)

  4 - ABEONA THERAPEUTICS INC. (0000318306) (Issuer)
• 132d
  Director Zeiher Bernhardt G was granted 37,313 shares, increasing direct ownership by 79% to 84,458 units (SEC Form 4)

  4 - ABEONA THERAPEUTICS INC. (0000318306) (Issuer)
• 132d
  Director Alland Leila was granted 37,313 shares, increasing direct ownership by 24% to 191,679 units (SEC Form 4)

  4 - ABEONA THERAPEUTICS INC. (0000318306) (Issuer)
• 132d
  Director Alvino Mark was granted 37,313 shares, increasing direct ownership by 77% to 86,065 units (SEC Form 4)

  4 - ABEONA THERAPEUTICS INC. (0000318306) (Issuer)
• 132d
  Director Amoroso Michael was granted 37,313 shares, increasing direct ownership by 21% to 217,779 units (SEC Form 4)

  4 - ABEONA THERAPEUTICS INC. (0000318306) (Issuer)
• 132d
  Director Silverstein Christine Berni was granted 37,313 shares, increasing direct ownership by 31% to 157,792 units (SEC Form 4)

  4 - ABEONA THERAPEUTICS INC. (0000318306) (Issuer)
• 132d
  Director Charles Faith L. was granted 37,313 shares, increasing direct ownership by 27% to 176,407 units (SEC Form 4)

  4 - ABEONA THERAPEUTICS INC. (0000318306) (Issuer)
• 133d
  Chief Commercial Officer Vasanthavada Madhav was granted 76,621 shares and sold $66,658 worth of shares (12,610 units at $5.29), increasing direct ownership by 25% to 318,619 units (SEC Form 4)

  4 - ABEONA THERAPEUTICS INC. (0000318306) (Issuer)
• 133d
  New insider Vasanthavada Madhav claimed ownership of 254,608 shares (SEC Form 3)

  3 - ABEONA THERAPEUTICS INC. (0000318306) (Issuer)
• 136d
  Chief Financial Officer Vazzano Joseph Walter sold $99,507 worth of shares (18,666 units at $5.33), decreasing direct ownership by 3% to 568,560 units (SEC Form 4)

  4 - ABEONA THERAPEUTICS INC. (0000318306) (Issuer)
• 136d
  Chief Executive Officer Seshadri Vishwas sold $372,267 worth of shares (69,832 units at $5.33), decreasing direct ownership by 5% to 1,460,408 units (SEC Form 4)

  4 - ABEONA THERAPEUTICS INC. (0000318306) (Issuer)
• 136d
  SVP, Chief Legal Officer O'Malley Brendan M. sold $72,383 worth of shares (13,578 units at $5.33), decreasing direct ownership by 3% to 451,134 units (SEC Form 4)

  4 - ABEONA THERAPEUTICS INC. (0000318306) (Issuer)
• 138d
  Director Alvino Mark sold $70,574 worth of shares (13,500 units at $5.23), decreasing direct ownership by 22% to 48,752 units (SEC Form 4)

  4 - ABEONA THERAPEUTICS INC. (0000318306) (Issuer)
• 139d
  Chief Financial Officer Vazzano Joseph Walter was granted 133,595 shares, increasing direct ownership by 29% to 587,226 units (SEC Form 4)

  4 - ABEONA THERAPEUTICS INC. (0000318306) (Issuer)
• 139d
  Chief Executive Officer Seshadri Vishwas was granted 365,422 shares, increasing direct ownership by 31% to 1,530,240 units (SEC Form 4)

  4 - ABEONA THERAPEUTICS INC. (0000318306) (Issuer)
• 139d
  SVP, Chief Legal Officer O'Malley Brendan M. was granted 113,949 shares, increasing direct ownership by 32% to 464,712 units (SEC Form 4)

  4 - ABEONA THERAPEUTICS INC. (0000318306) (Issuer)
• 161d
  Chief Executive Officer Seshadri Vishwas sold $132,740 worth of shares (25,000 units at $5.31), decreasing direct ownership by 2% to 1,164,818 units (SEC Form 4)

  4 - ABEONA THERAPEUTICS INC. (0000318306) (Issuer)
• 206d
  Director Alvino Mark sold $71,168 worth of shares (15,000 units at $4.74), decreasing direct ownership by 19% to 62,252 units (SEC Form 4)

  4 - ABEONA THERAPEUTICS INC. (0000318306) (Issuer)
• 235d
  Chief Executive Officer Seshadri Vishwas sold $1,366 worth of shares (249 units at $5.49), decreasing direct ownership by 0.02% to 1,189,818 units (SEC Form 4)

  4 - ABEONA THERAPEUTICS INC. (0000318306) (Issuer)
• 250d
  Chief Executive Officer Seshadri Vishwas sold $234,884 worth of shares (44,274 units at $5.31), decreasing direct ownership by 4% to 1,190,067 units (SEC Form 4)

  4 - ABEONA THERAPEUTICS INC. (0000318306) (Issuer)
• 250d
  SVP, Chief Legal Officer O'Malley Brendan M. sold $50,516 worth of shares (9,366 units at $5.39), decreasing direct ownership by 3% to 350,763 units (SEC Form 4)

  4 - ABEONA THERAPEUTICS INC. (0000318306) (Issuer)
• 250d
  Chief Financial Officer Vazzano Joseph Walter sold $48,730 worth of shares (9,035 units at $5.39), decreasing direct ownership by 2% to 453,631 units (SEC Form 4)

  4 - ABEONA THERAPEUTICS INC. (0000318306) (Issuer)
• 258d
  SVP, Chief Legal Officer O'Malley Brendan M. sold $3,736 worth of shares (688 units at $5.43), decreasing direct ownership by 0.19% to 360,129 units (SEC Form 4)

  4 - ABEONA THERAPEUTICS INC. (0000318306) (Issuer)
• 297d
  Director Crombez Eric sold $32,683 worth of shares (4,718 units at $6.93), decreasing direct ownership by 10% to 42,427 units (SEC Form 4)

  4 - ABEONA THERAPEUTICS INC. (0000318306) (Issuer)
• 297d
  Chief Financial Officer Vazzano Joseph Walter sold $110,358 worth of shares (15,000 units at $7.36), decreasing direct ownership by 3% to 462,666 units (SEC Form 4)

  4 - ABEONA THERAPEUTICS INC. (0000318306) (Issuer)
• 321d
  Chief Financial Officer Vazzano Joseph Walter sold $9,975 worth of shares (1,502 units at $6.64), decreasing direct ownership by 0.31% to 477,666 units (SEC Form 4)

  4 - ABEONA THERAPEUTICS INC. (0000318306) (Issuer)
• 333d
  Chief Executive Officer Seshadri Vishwas sold $406,503 worth of shares (69,420 units at $5.86), decreasing direct ownership by 5% to 1,234,341 units (SEC Form 4)

  4 - ABEONA THERAPEUTICS INC. (0000318306) (Issuer)
• 333d
  Director Silverstein Christine Berni sold $76,669 worth of shares (13,093 units at $5.86), decreasing direct ownership by 10% to 120,479 units (SEC Form 4)

  4 - ABEONA THERAPEUTICS INC. (0000318306) (Issuer)
• 333d
  Chief Financial Officer Vazzano Joseph Walter sold $148,799 worth of shares (25,411 units at $5.86), decreasing direct ownership by 5% to 479,168 units (SEC Form 4)

  4 - ABEONA THERAPEUTICS INC. (0000318306) (Issuer)
• 333d
  SVP, Chief Legal Officer O'Malley Brendan M. sold $102,053 worth of shares (17,428 units at $5.86), decreasing direct ownership by 5% to 360,817 units (SEC Form 4)

  4 - ABEONA THERAPEUTICS INC. (0000318306) (Issuer)
• 333d
  Director Alvino Mark sold $76,669 worth of shares (13,093 units at $5.86), decreasing direct ownership by 14% to 77,252 units (SEC Form 4)

  4 - ABEONA THERAPEUTICS INC. (0000318306) (Issuer)
• 333d
  Director Wuchterl Donald A. sold $30,147 worth of shares (5,176 units at $5.82), decreasing direct ownership by 3% to 145,436 units (SEC Form 4)

  4 - ABEONA THERAPEUTICS INC. (0000318306) (Issuer)
• 333d
  Director Charles Faith L. sold $62,879 worth of shares (10,738 units at $5.86), decreasing direct ownership by 7% to 139,094 units (SEC Form 4)

  4 - ABEONA THERAPEUTICS INC. (0000318306) (Issuer)
• 364d
  Chief Financial Officer Vazzano Joseph Walter was granted 13,333 shares, increasing direct ownership by 3% to 504,579 units (SEC Form 4)

  4 - ABEONA THERAPEUTICS INC. (0000318306) (Issuer)
• 366d
  Chief Financial Officer Vazzano Joseph Walter sold $120,294 worth of shares (17,795 units at $6.76), decreasing direct ownership by 3% to 491,246 units (SEC Form 4)

  4 - ABEONA THERAPEUTICS INC. (0000318306) (Issuer)
• 366d
  Chief Executive Officer Seshadri Vishwas sold $342,570 worth of shares (50,676 units at $6.76), decreasing direct ownership by 4% to 1,303,761 units (SEC Form 4)

  4 - ABEONA THERAPEUTICS INC. (0000318306) (Issuer)
• 367d
  SVP, General Counsel O'Malley Brendan M. sold $70,777 worth of shares (10,470 units at $6.76), decreasing direct ownership by 3% to 378,245 units (SEC Form 4)

  4 - ABEONA THERAPEUTICS INC. (0000318306) (Issuer)
• 370d
  Chief Executive Officer Seshadri Vishwas covered exercise/tax liability with 885 shares, decreasing direct ownership by 0.07% to 1,354,437 units (SEC Form 4)

  4 - ABEONA THERAPEUTICS INC. (0000318306) (Issuer)
• 376d
  Director Alvino Mark sold $12,760 worth of shares (2,000 units at $6.38), decreasing direct ownership by 2% to 90,435 units (SEC Form 4)

  4 - ABEONA THERAPEUTICS INC. (0000318306) (Issuer)
• 388d
  Director Alvino Mark sold $45,440 worth of shares (8,000 units at $5.68), decreasing direct ownership by 8% to 92,435 units (SEC Form 4)

  4 - ABEONA THERAPEUTICS INC. (0000318306) (Issuer)
• 433d
  Chief Executive Officer Seshadri Vishwas sold $119,500 worth of shares (25,000 units at $4.78), decreasing direct ownership by 2% to 1,355,322 units (SEC Form 4)

  4 - ABEONA THERAPEUTICS INC. (0000318306) (Issuer)
• 448d
  Chief Financial Officer Vazzano Joseph Walter covered exercise/tax liability with 685 shares, decreasing direct ownership by 0.13% to 509,041 units (SEC Form 4)

  4 - ABEONA THERAPEUTICS INC. (0000318306) (Issuer)
• 461d
  SVP, General Counsel O'Malley Brendan M. covered exercise/tax liability with 181 shares, decreasing direct ownership by 0.05% to 388,715 units (SEC Form 4)

  4 - ABEONA THERAPEUTICS INC. (0000318306) (Issuer)
• 489d
  Director Charles Faith L. was granted 36,101 shares, increasing direct ownership by 32% to 149,832 units (SEC Form 4)

  4 - ABEONA THERAPEUTICS INC. (0000318306) (Issuer)
• 489d
  Director Silverstein Christine Berni was granted 36,101 shares, increasing direct ownership by 37% to 133,572 units (SEC Form 4)

  4 - ABEONA THERAPEUTICS INC. (0000318306) (Issuer)
• 489d
  Director Wuchterl Donald A. was granted 36,101 shares, increasing direct ownership by 32% to 150,612 units (SEC Form 4)

  4 - ABEONA THERAPEUTICS INC. (0000318306) (Issuer)